About
Hanimune Therapeutics develops consumer food products designed to prevent and manage food allergies by delivering controlled doses of common allergens to build tolerance, including products like 'Lil Mixins' for early infant allergen introduction and 'Top9Proteins' formulations with consistent allergen quantities.
Explore Hanimune Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.